Pharmaceutical Research

, Volume 24, Issue 4, pp 618–627

Encapsulation of Nucleic Acids and Opportunities for Cancer Treatment

  • Lisa Brannon-Peppas
  • Bilal Ghosn
  • Krishnendu Roy
  • Kenneth Cornetta
Expert Review

DOI: 10.1007/s11095-006-9208-x

Cite this article as:
Brannon-Peppas, L., Ghosn, B., Roy, K. et al. Pharm Res (2007) 24: 618. doi:10.1007/s11095-006-9208-x

Abstract

The development of nucleic acid drugs for the treatment of various cancers has shown great promise in recent years. However, efficient delivery of these drugs to target cells remains a significant challenge towards the successful development of such therapies. This review provides a comprehensive overview of encapsulation technologies being developed for the delivery of nucleic acid-based anti-cancer agents. Both micro and nanoparticles systems are discussed along with their use in delivering plasmid DNA as well as oligonucleotides. The majority of the systems discussed have used DNA immunotherapy as the potential mode of anticancer therapy, which requires targeting to antigen presenting cells. Other applications, including those with oligonucleotides, focus on targeting tumor cells directly. The results obtained so far show the excellent promise of encapsulation as an efficient means of delivering therapeutic nucleic acids.

Key words

encapsulation cancer DNA gene particles 

Copyright information

© Springer Science+Business Media, LLC 2007

Authors and Affiliations

  • Lisa Brannon-Peppas
    • 1
  • Bilal Ghosn
    • 2
  • Krishnendu Roy
    • 2
  • Kenneth Cornetta
    • 3
  1. 1.Department of Biomedical Engineering and College of PharmacyThe University of Texas at AustinAustinUSA
  2. 2.Department of Biomedical EngineeringThe University of Texas at AustinAustinUSA
  3. 3.Department of Medical and Molecular GeneticsIndiana University School of MedicineIndianapolisUSA

Personalised recommendations